5Honkoop P, Man RA, Zondervan PE, et al. Histological improvment in patients with chronic hepatitis B virus infection reated with lamivudine [J]. Liver, 1997, 17 (2) :103.
6Villeneuve JP, Condreay LD, Willems B, et al. Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B [J]. Hepatology, 2000, 31 (1): 207.
7Tassopoulos NC, Volpes R, Pastore G, et al. Efficacy of lamivudine in patients with hepatitis B e antigen-negativ/hepatitis B virus DNA positive ( precore mutant) chronic hepatitis 13 [J].Hepatology, 1999, 29: 889.
8Chayama K, Suzuki Y, Kobayashi M, et al. Emergence and takeover of YMDD motif mutant hepatitis B virus during longterm lamivudine therapy and re-takeover by wild type after cessation of therapy[J]. Hepatology, 1998,27(6):1711.
9Kirishima T, Okanoue T, Daimon Y, et al. Detection of YMDD mutant using a novel sensitive method in chronic liver disease type B patients before and during lamivudine treatment [J]. J Hepatol, 2002: 37(2):259.
10Ling R, Mutimer D, Ahmed M, et al. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine [J]. Hepatology, 1996, 24 (3) : 711.
